Friday 19th April 2019
Home General Business News Royal visitor sees expanding Cambs pharma business

Royal visitor sees expanding Cambs pharma business

E-mail Print PDF

Cambs-based biotech firm LGC hosted a visit by The Princess Royal to its recently expanded laboratories at its site in Fordham, last week.

She met with scientists and apprentices to hear how the company’s analytical science supports doping and medication control in animal sports and helps develop new drugs and therapies.

Dr David Griffiths, managing director, pharma and health solutions, LGC, and who hosted the visit said: “…With her background as a former member of Great Britain’s Olympic equestrian team, as well as her current roles as president of the British Olympic Association and member of the International Olympic Committee, we were obviously keen to show her the labs from which we successfully tested the equestrian events at the 2012 London and 2016 Rio de Janeiro Olympics and Paralympics. Her interest in, and knowledge of, science and encouraging young people to study STEM subjects at school also provided some fascinating discussions between Her Royal Highness and our teams.”

LGC’s Fordham site is one of the largest bioanalytical centres in Europe and employs around 380 scientists. It will host open sessions for people interested in its apprenticeship scheme on 16 April.

Separately, Cambridge-based Metrion Biosciences, a specialist ion channel contract research and drug discovery company, has completed a fully subscribed funding round. It will use the funds to support the broadening of its ion channel screening capabilities and continued research.

Last Updated ( Wednesday, 03 April 2019 09:43 )